ArticleOncotarget2017
Plasma microRNA alterations between EGFR-activating mutational NSCLC patients with and without primary resistance to TKI.
Yihan Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papercites it